TPWA
JAZZ icon

Twin Peaks Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.1K Buy
+27
New +$4.72K ﹤0.01% 1384
2025
Q3 		– Sell
-18
Closed -$2.04K – 1162
2025
Q2 		$2.04K Buy
+18
New +$1.96K ﹤0.01% 1618

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Twin Peaks Wealth Advisors's JAZZ Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 27 shares worth $5.1K. The stake represents ﹤0.01% of the portfolio and ranks #1384 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in JAZZ as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in JAZZ in Q2 2025 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Twin Peaks Wealth Advisors held 27 shares of Jazz Pharmaceuticals worth $5.1K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #1384 holding.
  • Twin Peaks Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.